Find investors
← Back to all investors
James Wise
ResearchedAngel Investors

James Wise

Partner

Angel InvestorsSeed Round
Pitch James

Get their honest, personalized take on your startup.

Sign in to pitch James

At a glance

Full Name
James Wise
Title
Partner
Firm
Balderton Capital
Firm Type
Venture capital firm
Investment Stage
Seed to pre-IPO; James says he spends more time on Series A-B investments
Check Size
Balderton Growth has stated $25M-$50M per company; James's individual Balderton check size is not separately published
Target Company Profile
European-founded technology companies with global ambition, early product validation, strong founding teams, and software leverage; for James's stated areas, companies with clear proof points, defensibility, and scalable go-to-market
Sector Focus
AI, productivity, energy, health/healthtech, sustainability, and selected defense/dual-use technology
Geographic Focus
Europe; UK focus in his Sovereign AI role
Location
London, United Kingdom

Background

James Wise is a Partner at Balderton Capital, a European venture firm focused on technology companies. Balderton's own profile says he joined the firm in 2013 and became a Partner in 2016; his personal site says he has spent more than a decade investing in and supporting UK and European technology companies.

Before Balderton, Wise helped launch and run one of the UK's first social venture funds. He has also worked with entrepreneurs and businesses in Europe and Africa and worked as a consultant at McKinsey & Company. Public biographies also note that he holds an MA from the University of Oxford.

Wise is active beyond venture investing. He is the author of *Start-Up Century*, published by Bloomsbury Business, and has written or contributed to outlets including The Times, The Guardian, The Telegraph, and the BBC. He has been a member of the UK Government's Industrial Development Advisory Board, a trustee of Demos, and in 2025 was appointed inaugural Chair of the UK Government's Sovereign AI Unit, described on his site as a £500M fund and AI-solutions group.

Investment Thesis & Focus

  • Wise describes Balderton as sector-agnostic, backing "the best founders using technology to change the world for the better in every sector where software provides leverage."
  • His stated personal focus areas are "AI for All, the Great Energy Transition and Scaleable Healthcare."
  • He invests from seed to pre-IPO, but has said he spends more time on Series A-B opportunities.
  • For AI, he looks for products that outperform benchmarks, have a theory for improving at scale, and build defensibility around models, interfaces, infrastructure, or workflows.
  • For energy and sustainability, he is interested in technical breakthroughs and software solutions that can improve sustainability at scale, particularly by reducing or removing carbon emissions.
  • For healthcare, he looks for software with scalable go-to-market and, increasingly, medical devices or personalized therapeutics with proof of effectiveness, clinical data or regulatory milestones, and early professional adoption.
  • Wise has emphasized conviction as Balderton's differentiator, writing that "conviction is what makes a great partner in a venture investor."

Notable Investments

  • GoCardless - Payments infrastructure company; Balderton invested in 2015 and Wise described Balderton as one of its earliest investors and largest shareholders when GoCardless agreed to join Mollie in a €1.1B cash-and-shares deal in 2025.
  • Depop - Social fashion marketplace; Balderton first invested in Depop's 2012 seed round, and Etsy announced its acquisition of Depop for $1.625B in 2021.
  • Convergence - AI-agent company; Balderton announced its seed investment less than nine months before Convergence was acquired by Salesforce in May 2025.
  • Quantum Systems - Munich-based aerial intelligence and drone company; Balderton led its $160M round in 2025, and Wise later wrote about its $1.2B Series D in July 2026.
  • Prior Labs - Freiburg-based AI company building tabular foundation models; Balderton led its seed round, and SAP announced intent to acquire Prior Labs in a €1B+ transaction in May 2026.
  • Sava - London healthtech company developing minimally invasive continuous molecular monitoring; Wise wrote in February 2026 that Sava had raised over £20M and was targeting commercial availability in early 2027.
  • Sophia Genetics - AI and bioinformatics company; Wise is listed as working with the company, which is Nasdaq-listed as SOPH.
  • Tibber - Smart energy provider; Balderton-backed company in Wise's energy thesis.
  • deepset - Enterprise AI platform company; Wise wrote in 2023 that Balderton invested as part of its enterprise AI and open-source software thesis.
  • Sketchfab - 3D content platform; Balderton first invested in its seed round in 2013, Wise joined the board, and Epic Games acquired Sketchfab in 2021.
  • 3D Hubs - Distributed manufacturing platform; Wise wrote that Protolabs acquired the Balderton portfolio company in a $330M cash-and-shares deal in 2021.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.